Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiang J Li

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of Cellular Physiology|September 27, 2006
Therapeutic biology: checkpoint pathway activation therapy, HIV Tat, and transkingdom RNA interferenceChiang J Li
Journal of Cellular Physiology|June 1, 2018
Two controls of cell proliferation underlie cancer relapseArthur B Pardee, Chiang J Li
Nature Biotechnology|May 16, 2006
Short hairpin RNA-expressing bacteria elicit RNA interference in mammalsShuanglin Xiang, Johannes Fruehauf, Chiang J Li
Nature Biotechnology|November 26, 2008
Asymmetric RNA duplexes mediate RNA interference in mammalian cellsXiangao Sun, Harry A Rogoff, Chiang J Li
Methods in Molecular Biology (Clifton, N.J.)|June 4, 2021
Synthetic Biology Medicine and Bacteria-Based Cancer TherapeuticsJaehyung Lee, Andrew C Keates, Chiang J Li
Current Cancer Drug Targets|August 22, 2002
Cancer therapy with beta-lapachoneArthur B Pardee, You Zhi Li, Chiang J Li
Cell Cycle (Georgetown, Tex.)|July 21, 2006
Genomic instability in precancerous lesions before inactivation of tumor suppressors p53 and APC in patientsYouxin Yang, Johannes Fruehauf, Shuanglin Xiang, et al.
Cell Cycle (Georgetown, Tex.)|October 7, 2004
Regulation in S phase by E2FArthur B Pardee, Chiang J Li, G Prem Veer Reddy
Biotechnology & Genetic Engineering Reviews|March 18, 2011
TransKingdom RNA interference: a bacterial approach to challenges in RNAi therapy and deliveryAndrew C Keates, Johannes Fruehauf, Shuanglin Xiang, et al.
Cancer Research|September 6, 2005
Cancer chemotherapy by deoxynucleotide depletion and E2F-1 elevationAjin Wang, Chiang J Li, Prem V Reddy, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Cellular Physiology|September 27, 2006
Therapeutic biology: checkpoint pathway activation therapy, HIV Tat, and transkingdom RNA interferenceChiang J Li
Journal of Cellular Physiology|June 1, 2018
Two controls of cell proliferation underlie cancer relapseArthur B Pardee, Chiang J Li
Nature Biotechnology|May 16, 2006
Short hairpin RNA-expressing bacteria elicit RNA interference in mammalsShuanglin Xiang, Johannes Fruehauf, Chiang J Li
Nature Biotechnology|November 26, 2008
Asymmetric RNA duplexes mediate RNA interference in mammalian cellsXiangao Sun, Harry A Rogoff, Chiang J Li
Methods in Molecular Biology (Clifton, N.J.)|June 4, 2021
Synthetic Biology Medicine and Bacteria-Based Cancer TherapeuticsJaehyung Lee, Andrew C Keates, Chiang J Li
Current Cancer Drug Targets|August 22, 2002
Cancer therapy with beta-lapachoneArthur B Pardee, You Zhi Li, Chiang J Li
Cell Cycle (Georgetown, Tex.)|July 21, 2006
Genomic instability in precancerous lesions before inactivation of tumor suppressors p53 and APC in patientsYouxin Yang, Johannes Fruehauf, Shuanglin Xiang, et al.
Cell Cycle (Georgetown, Tex.)|October 7, 2004
Regulation in S phase by E2FArthur B Pardee, Chiang J Li, G Prem Veer Reddy
Biotechnology & Genetic Engineering Reviews|March 18, 2011
TransKingdom RNA interference: a bacterial approach to challenges in RNAi therapy and deliveryAndrew C Keates, Johannes Fruehauf, Shuanglin Xiang, et al.
Cancer Research|September 6, 2005
Cancer chemotherapy by deoxynucleotide depletion and E2F-1 elevationAjin Wang, Chiang J Li, Prem V Reddy, et al.
Pageof 3